Showing 17 of 17 recruiting trials for “granulomatous-slack-skin”
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
👨⚕️ Paul Szabolcs, MD, UPMC Children's Hospital of Pittsburgh📍 1 site📅 Started Mar 2026View details ↗
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2025View details ↗
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
RecruitingNCT06605378 ↗
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Effect of Different Surgical Approaches of Granulomatous Mastitis
RecruitingNCT06665399 ↗
Observation Alone for Mild Non-Lactational Mastitis
RecruitingNCT06667609 ↗
Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis
RecruitingNCT06565845 ↗
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
👨⚕️ Jing Feng, First Affiliated Hospital of Harbin Medical University📍 1 site📅 Started Aug 2024View details ↗
pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jun 2024View details ↗
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
👨⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Apr 2024View details ↗
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
👨⚕️ Christa S Zerbe, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
👨⚕️ Suchitra K Hourigan, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
👨⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
👨⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
RecruitingNCT00128973 ↗
Evaluation of Patients With Immune Function Abnormalities
👨⚕️ Harry L Malech, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2005View details ↗
Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
👨⚕️ Harry L Malech, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Feb 1994View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →